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Background: Pain of various causes is a common phenomenon in patients with Multiple 
Sclerosis (MS). A biopsychosocial perspective has proven a useful theoretical construct in other 
chronic pain conditions and was also started in MS. To support such an approach, we aimed to 
investigate pain in MS with special emphasis on separating quantitative and qualitative aspects, 
and its interrelation to behavioral and physical aspects.
Materials and methods: Pain intensity (NRS) and quality (SES) were measured in 38 
consecutive outpatients with MS (mean age, 42.0 ± 11.5 years, 82% women). Pain-related 
behavior (FSR), health care utilization, bodily complaints (GBB-24) and fatigue (WEIMuS) 
were assessed by questionnaires, and MS-related neurological impairment by a standardized 
neurological examination (EDSS).
Results: Mean pain intensity was 4.0 (range, 0–10) and mean EDSS 3.7 (range, 0–8) in the 
overall sample. Currently present pain was reported by 81.6% of all patients. Disease duration 
and EDSS did not differ between patients with and without pain and were not correlated to 
quality or intensity of pain. Patients with pain had significantly higher scores of musculoskel-
etal complaints, but equal scores of exhaustion, gastrointestinal and cardiovascular complaints. 
Pain intensity correlated only with physical aspects, whereas quality of pain was additionally 
associated with increased avoidance, resignation and cognitive fatigue.
Conclusion: As in other conditions, pain in MS must be assessed in a multidimensional way. 
Further research should be devoted to adapt existing models to a MS-specific model of pain.
Keywords: pain intensity, quality of pain, pain-related behavior, bodily complaints, multiple 
sclerosis
Introduction
Multiple sclerosis (MS) is a chronic immune-mediated disease of the central ner-
vous system that often leads to long-term physical disability.1 Throughout the course 
of the disease, pain is a common, varying symptom and a significant problem.2 In 
23% of patients with MS, pain was found as part of the presenting symptoms at 
disease onset.3 Previous studies have reported remarkable pain prevalences up to 
79.4% and 92% in patients with MS.4,5 Pain in MS patients can be caused directly 
by inflammatory attack on afferent fiber tracts, or indirectly by various sequelae of 
MS (eg, limb paresis, extrapyramidal or cerebellar syndromes, bladder dysfunction),1 
leading to increased muscle tone with spasms, postural abnormalities, or urinary 





the other hand, pain in MS influences many aspects of daily 
living2,8,9 (eg, important domains of health-related quality 
of life)10 and physical activity.11,12 The consequences of pain 
in MS should be assessed with a focus on psychosocial 
aspects – an issue that has received insufficient attention in 
numerous   previous studies.2,13 The available data suggest 
that depression, pain behavior, health care utilization,   coping 
behavior, and beliefs might be important determinants of 
pain.2,6,13–16 In other painful conditions – such as low back 
pain –   biopsychosocial models, which describe interactions 
of bodily pain with cognitive, behavioral, and social variables, 
have proven useful in understanding the complex conditions 
of the disorder and guiding interventions.17–20 Kerns et al6,13 
proposed a multidimensional model for pain in MS; amongst 
others, behavioral aspects have received more attention in 
this model. For example, muscle weakness can contribute 
to more generalized deconditioning and increased musculo-
skeletal complaints; these changes, in combination with fear 
of pain, contribute to avoidance behavior with a consecutive 
worsening of muscle weakness and thus additional pain.6 
The usefulness of this analytical process in MS patients was 
underscored by a recent study by Motl et al,21 who focused on 
behavioral aspects, especially physical activity. They found 
that MS patients who were more physically active had lower 
scores of pain along with reduced depression and fatigue, as 
well as improved self-esteem. Comparable data were also 
presented by Turner et al.22 Another investigation showed a 
significant association of pain beliefs and coping strategies 
with pain intensity scores in patients with MS.15 Generally, 
previous studies in MS patients often assessed pain in a 
dichotomous way, providing the proportion of patients with 
and without pain.9–12 This was sometimes supplemented 
with quantifying pain intensity using rating scales.5,9–12,16,23 
One aspect that has been incompletely addressed – especially 
in the field of neuropathic pain – is recording both pain 
intensity and quality of pain.24
The aims of the present study were (1) to investigate 
both pain intensity and quality of pain in MS patients – 
  predominantly in a quantitative modality – and (2) to analyze 
their interrelations to physical (bodily complaints, fatigue) 
and behavioral factors (pain-related behavior, health care 
utilization), exploring the components of a biopsychosocial 
model applicable to MS.
Materials and methods
study design and population
In a prospective setting, unselected consecutive outpatients 
attending the Department of Neurology of the University of 
Leipzig in 2007 with an established diagnosis of MS were 
asked to participate in a survey using a standardized paper-
and-pencil questionnaire. Data from 49 participants were 
available; 38 of these subjects provided information about 
pain and were analyzed.
Assessments
Pain intensity (NRS) was assessed with a numerical rating 
scale (scaled from 0 to 10)25 addressing the average pain, 
which is associated with MS according to the patient’s point 
of view. Thereby, 0 represents no pain and 10 the most   painful 
sensation imaginable. In addition, the lowest and highest 
intensity of pain were recorded.
Quality of pain (SES) was measured by the pain sensation 
scale.26 This tool contains 24 adjectives of pain sensation in 
a questionnaire; each of them is scaled from 1 to 4.   Fourteen 
items comprise the affective dimension, and ten items con-
tribute to the sensory dimension.
Bodily complaints (GBB-24) were measured using the 
short version of the Giessen-subjective complaints list.27 
In this questionnaire patients rate a list of 24 complaints 
according to currently perceived severity from 0 to 4. The 
items are attributed equally to four dimensions: exhaustion, 
gastrointestinal complaints, musculoskeletal complaints and 
cardiovascular complaints. The total score of complaints 
equals the sum of the four dimensions. The GBB-24 is one 
of the most commonly used complaints lists in Germany and 
was standardized using the German population.28
Fatigue (WEIMuS) was assessed by the Würzburg fatigue 
inventory for multiple sclerosis as described by Flachenecker 
et al.29 In this questionnaire 17 items (scaled from 0 to 4) 
are listed, resulting in two dimensions: cognitive fatigue 
and physical fatigue. The scale combines items from the 
Fatigue Severity Scale (FSS) and the Modified Fatigue 
Impact Scale (MFIS) simplifying the partly overlapping 
scales; it has been validated in a German MS population 
and found to reflect all aspects covered when administering 
the separate scales.29
Pain-related behavior (FSR) was measured with the 
dimensions avoidance, resignation and distraction of the 
Questionnaire on Pain Regulation; in each case eight items 
(scaled from 1 to 7) generate one dimension.30
Health care utilization reflects the self-reported number 
of MS-related physician consultations, physician changes, 
days off work, physical therapies, days of hospitalization and 
surgical interventions within the last 12 months.
The severity of neurological impairment due to MS was 
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the most common scale to measure impairment in MS 
patients ranging from 0 to 10 in 0.5 increments,32 around the 
time of completing the questionnaire.
For all measurements, higher values correspond to higher 
intensity of each respective dimension.
statistical analyses
Questionnaire scores (GBB-24, SES, WEIMuS and FSR) 
were calculated as rounded means with a tolerance of one 
missing item per scale. Descriptive statistics were applied for 
sample descriptions. For differences between two groups, the 
Kolmogorov–Smirnov test was used. Analysis of Variance 
(ANOVA) was applied for differences between more than 
two groups, followed by the Duncan test for multiple com-
parisons. Relations between variables were analyzed using 
Pearson’s correlations. Data are given as mean ± standard 
deviation, unless otherwise indicated. All calculations were 
performed with SPSS (v 18.0; SPSS Inc, an IBM Company, 
Chicago, IL). A P-value ,0.05 was considered statistically 
significant.
Results
The present sample of 38 patients with MS consisted of 
seven men (18.4%) and 31 women (81.6%). Patients’ 
mean age was 42.0 ± 11.5 years (range, 21–69) and all 
were native   Germans. The mean disease duration was 
8.6 ± 7.3 years (range, 1–26). The clinical course of MS was 
  relapsing-remitting in 24 (RR; 63.2%), secondary progressive 
in seven (SP; 18.4%), and primary progressive in five patients 
(PP; 13.2%). Two patients (5.2%) suffered from a clinical 
isolated syndrome of CNS demyelination (CIS). Due to the 
small number, the latter group was not used for analysis of 
differences according to the clinical course.
Pain intensity and quality of pain
Table 1 gives an overview on pain intensity and quality of 
pain as well as the physical and behavioral aspects. There was 
no significant difference between men and women for pain 
intensity (men, 3.9 ± 3.0; women, 4.1 ± 2.6; P = 1.000), nor 
for sensory (men, 21.0 ± 8.9; women, 16.4 ± 6.5; P = 0.726) 
or affective dimensions of pain quality (men, 29.3 ± 13.0; 
women, 26.8 ± 10.7; P = 0.898). Age did not correlate 
with pain intensity (r = 0.14; P = 0.390), sensory (r = 0.18; 
P = 0.328) or affective (r = 0.20; P = 0.281) dimensions of 
pain quality. Course of MS (RR, SP and PP) did not differ 
with respect to pain intensity, affective or sensory quality of 
pain (P = 0.721; P = 0.243; P = 0.413, respectively). Disease 
duration was not correlated with pain intensity (r = 0.24; 
P = 0.143), affective (r = 0.26; P = 0.174) or sensory 
(r = 0.14; P = 0.470) dimensions of pain quality.
Table 1 Pain intensity and quality, as well as physical and behavioral aspects in the overall sample
Mean Standard deviation Range
Pain Pain intensity 4.0 2.6 0–10
Pain quality
Affective dimension 27.1 10.9 14–51
Sensory dimension 17.0 6.9 9–33
Physical aspects eDss 3.7 2.4 0–8
Bodily complaints
Exhaustion 12.0 5.4 0–21
Gastrointestinal complaints 2.9 2.9 0–12
Musculoskeletal complaints 10.6 4.2 3–19
Cardiovascular complaints 3.9 3.3 0–12
Total score 29.4 12.5 6–55
Fatigue
Cognitive fatigue 13.3 9.4 0–36
Physical fatigue 17.5 8.6 0–31
Behavioral aspects Pain-related behavior
Avoidance 29.4 10.3 8–47
Resignation 31.9 10.5 9–50
Distraction 28.4 9.6 12–51
health care utilization (number within the last 12 months)
Physician consultations 9.1 5.3 2–25
Physician changes 0.2 0.5 0–2
Days off work 58.8 112.8 0–365
Physical therapies 45.0 68.8 0–260
Days of hospitalization 6.7 10.2 0–42






Among 38 patients, 31 reported pain intensity above zero. 
This results in 81.6% of patients experiencing pain at the time 
of completing the questionnaire. Patients with pain reported 
MS-related “highest pain intensity” of 7.1 ± 2.0 (range, 2–10) 
and “lowest pain intensity” of 2.0 ± 1.8 (range, 0–7).
Differences between Ms patients  
with pain vs no pain
MS patients with pain and those who had no pain were of 
equal age (pain, 42.4 ± 11.4 years; no pain, 40.0 ± 12.4 years; 
P = 0.871), had comparable neurological impairment 
(EDSS: pain, 3.8 ± 2.3; no pain, 3.1 ± 3.1; P = 0.556) 
and disease duration (pain, 8.9 ± 7.6 years; no pain, 
7.3 ± 6.2 years; P = 0.885). The direct comparisons between 
the pain and no pain group concerning bodily complaints 
and fatigue are shown in Figure 1. Those concerning pain-
related   behavior and health care utilization are illustrated 
in Figure 2.   Significant differences are only apparent for 
musculoskeletal complaints (P = 0.003) and total score of 
complaints (P = 0.033), with higher values for patients with 
pain. Patients with pain tended to increased avoidance and 
resignation, and attended fewer physical therapy sessions 
and had increased days off work, though with no statistical 
significance (P = 0.527; P = 0.265, respectively).
Relationship between pain and physical  
as well as behavioral aspects
Table 2 shows the interrelation of assessed parameters in terms 
of a correlation matrix. Pain intensity correlated significantly 
with musculoskeletal complaints and consecutively with total 
score of bodily complaints. A further significant coefficient 
was found for physical fatigue. Interestingly, there was no 
significant interrelation to behavioral aspects. The affective 
dimension of quality of pain was associated with exhaustion 
and total score of bodily complaints, and furthermore 
  physical fatigue. Concerning behavioral aspects, the affective 
dimension was significantly correlated with avoidance and 
resignation. The sensory dimension of quality of pain was 
significantly associated with physical aspects including all 
types of bodily complaints and fatigue, but not with severity 
of neurological impairment (EDSS). A further interrelation 
was found between the sensory dimension of pain and resig-
nation. Summarizing pain concerning different dimensions, 
the qualitative aspect of pain was substantially associated 
with pain-related behavior in contrast to the quantitative 
dimension. Moreover, pain intensity and quality of pain did 
not significantly interact with health care utilization (bottom 
of Table 2).
Discussion
Eighty-one percent of our unselected sample of outpatients 
with MS suffered from pain at the time of completing the 
questionnaire. This proportion is comparable with previ-
ous studies (eg, 79.4%),23 although higher (92%)5 and 
lower percentages have been reported as well (eg, 42.9% 
and 66%).4,12
Focusing on physical aspects of MS, the means for bodily 
complaints are increased nearly two-fold for exhaustion, 

























Figure 1 comparison of physical aspects (bodily complaints and fatigue) between Ms patients with and with no pain, displayed as means in bars and standard errors of 
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as compared to the German general population (means: 
exhaustion, 3.97; musculoskeletal complaints, 5.35; and total 
score of complaints, 14.03).28 Cognitive and physical fatigue 
are nearly equal to values that have been described by Flache-
necker et al29 who validated the WEIMuS scale in 67 patients 
with MS, which resulted in mean scores of 14.7 for cognitive 
fatigue and 19.9 for physical fatigue. Pain-related behavior in 
our sample was remarkably comparable to a group described 
as “back pain with low competence-estimation”, which was 
composed of 73 patients and listed in the user manual of 
the questionnaire (means for comparison: avoidance, 28.34; 
resignation, 33.21; and distraction, 29.30).30
The fact that pain – irrespective of pain intensity or 
quality – did not correlate with age, disease duration, or sever-
ity of impairment due to MS (EDSS) confirms and extends 
earlier findings,3,5,10,12,16 though two other studies did obtain 
positive correlations to age and disease duration,4 as well 
as to EDSS.4,11 However, differing pain assessments and 
aims might be possible explanations. In detail, Solaro et al4 
recorded presence of neuropathic, somatic, or visceral pain 
without evaluation of intensity. In contrast, Ehde et al11 used 
an 11-point rating scale for pain assessment in a large com-
munity sample of MS, but focused on pain-related activity 






















Figure 2 comparison of behavioral aspects (pain-related behavior and health care utilization) between Ms patients with and with no pain, displayed as means in bars and 
standard errors of means in lines.
Table 2 correlation matrix of pain (intensity, affective and sensory dimension), physical and behavioral aspects in patients with Ms
Pain intensity  
r (P-value)
Affective dimension  
of pain quality  
r (P-value)
Sensory dimension 
of pain quality  
r (P-value)
Physical aspects eDss 0.23 (0.158) 0.09 (0.639) 0.01 (0.978)
Bodily complaints
Exhaustion 0.32 (0.052) 0.56 (0.001) 0.41 (0.021)
Gastrointestinal complaints 0.06 (0.747) 0.29 (0.125) 0.40 (0.025)
Musculoskeletal complaints 0.65 (0.000) 0.35 (0.062) 0.49 (0.006)
Cardiovascular complaints 0.24 (0.152) 0.17 (0.362) 0.49 (0.006)
Total score 0.43 (0.007) 0.48 (0.008) 0.56 (0.001)
Fatigue
Cognitive fatigue 0.19 (0.246) 0.24 (0.202) 0.56 (0.001)
Physical fatigue 0.33 (0.044) 0.49 (0.006) 0.53 (0.002)
Behavioral aspects Pain-related behavior
Avoidance 0.12 (0.496) 0.58 (0.001) 0.35 (0.053)
Resignation 0.07 (0.695) 0.46 (0.010) 0.36 (0.048)
Distraction -0.01 (0.950) -0.29 (0.125) 0.04 (0.853)
health care utilization
Physician consultations 0.15 (0.431) 0.41 (0.055) 0.22 (0.314)
Physician changes 0.09 (0.648) 0.14 (0.540) 0.08 (0.742)
Days off work 0.36 (0.102) -0.21 (0.416) 0.22 (0.385)
Physical therapies -0.19 (0.330) -0.03 (0.904) -0.15 (0.507)
Days of hospitalization 0.00 (0.984) -0.13 (0.566) -0.10 (0.644)
Surgical interventions – – –





rating scale. Notwithstanding these heterogeneous findings, 
the lack of gender-related differences in pain intensity and 
quality has been consistently reported.2,3,11,12
With respect to a biopsychosocial perspective of pain in 
MS, it is remarkable that pain was not significantly correlated 
with EDSS or disease duration. This underscores the need to 
incorporate physical aspects apart from solely neurological 
impairment and psychosocial issues. Musculoskeletal com-
plaints were significantly different between the pain and no 
pain group. This, together with the known predominant pain 
localization of MS patients – in legs and lower back (74.6% 
and 59.3%) and neck and shoulders (51.7% and 49.2%)12 – 
primarily reflects chronic postural misadjustments. However, 
the recognition of rather prevalent associations with rheuma-
toid arthritis and recently with the TNF receptor associated 
periodic syndrome (TRAPS)33 add further potentially treat-
able physical factors. With respect to psychosocial issues, 
Kerns et al6,13 especially emphasized cognitive, behavioral 
and social issues in their biopsychosocial pain model. 
In line with this extended perspective, Arnett et al14 recently 
presented a model of MS-specific depression and thereby 
pointed out the inconsistent association to physical disability, 
but supported the use of psychosocial variables (eg, coping 
and social support). In the behavioral domain, the tendency 
of increased days off work in patients with pain – which has 
been found in this study and also by Ehde et al12 – confirms 
its socioeconomic consequences in MS.
The differentiated analysis of associations between pain 
intensity and quality as well as physical and behavioral aspects 
was performed in the whole sample size, thus representing a 
quantitative assessment. Overall, more significant coefficients 
were found for quality of pain when compared with pure pain 
intensity – this underscores the point of view that pain in 
MS must be measured by using such differentiated scores, 
analogous to peripheral neuropathic pain.24 More specifically, 
the affective and sensory dimensions of quality of pain had 
an impact on pain-related behavior, while increasing pain 
led to augmented avoidance and resignation. The propensity 
to avoidance is comparable to the mechanisms attributed 
to chronic low back pain,18 and suggests that beliefs19 and 
coping strategies15,20 similarly affect pain in MS patients. An 
increased affective pain dimension, linked to exhaustion and 
total score of complaints, might lead to avoidance behavior, 
bodily deconditioning and thus more pain. This postulation 
proves similar to the model of Kerns et al.6,13 The additional 
effect of fatigue due to pain and behavioral avoidance 
can be inferred from the correlation of both affective and 
sensory pain dimensions to fatigue. Such interactions of 
pain, avoidance and fatigue were also addressed in the 
biopsychosocial model of Kerns et al,6 and the connection 
of pain and fatigue in general has been noted previously.34 
Consistent with this direction, and potentially adding another 
therapeutic opportunity, is the nonsignificant negative 
correlation of affective pain and distraction. Exaggerated 
pain perception due to fear of pain, which can be caused 
by increased interoception, might prevent patients from 
seeking distraction from painful sensations.17 Furthermore, 
bodily deconditioning and social isolation reduce joyful 
experience, in turn contributing to affective disorders such 
as depression.6,14
The present study had some limitations: First, the sample 
size was relatively small, affecting the validity of the study 
conclusions. Despite this limitation, our study revealed some 
significant interactions in a biopsychosocial approach of pain 
in MS, which might be useful in exploring a MS-specific pain 
model. According to a multifactorial perspective, affective 
components like depression were not addressed, though 
these issues of MS are garnering increasing interest in recent 
years.14 However, this study was clearly aimed at pain inten-
sity and quality in relation to physical and behavioral factors. 
Focusing on pain assessment in general, the use of NRS has 
sometimes been criticized,35 but sufficiently evaluated tools 
for multidimensional pain measurement are still lacking.
In summary, physical activity should be encouraged in 
MS patients with pain in order to prevent bodily decondi-
tioning, secondary fatigue, social isolation and increased 
pain   sensation. This model is supported by the finding 
that MS patients who are more physically active suffer 
less from fatigue, pain and depression.21,22 However, neu-
rological impairment due to MS – eg, spasms or postural 
abnormalities – often leads to patients avoiding activity and 
must be taken into account. The therapeutic challenge is to 
integrate information about individual physical etiology with 
the analysis of behavioral aspects in an effort to intercept 
self-amplifying pain mechanisms. Cognitive-behavioral 
interventions are expected to be useful in this approach.15,16
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